• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911416270
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Myocardial Infarction (1969); Reocclusion (1985)
Event Date 01/24/2018
Event Type  Injury  
Manufacturer Narrative
Age at time of event: 18 years or older.Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that angina, myocardial infarction and in-stent restenosis occurred.In (b)(6) 2013, the patient presented due to myocardial infarction and was referred for cardiac catheterization.On the next day, coronary angiography and the index procedure were performed.The target lesion #1 was located in the proximal left anterior descending (lad) artery with 90% in-stent restenosis (isr) of bare metal stent (bms) and was 15mm long with a reference vessel diameter of 2.75mm.Target lesion #1 was treated with pre-dilatation and placement of a 2.75x16mm promus element¿ plus drug-eluting stent.Following post dilatation, residual stenosis was 0%.The target lesion #2 was a de novo lesion located in the proximal left circumflex (lcx) artery with 80% stenosis and was 10mm long with a reference vessel diameter of 2.75mm.Target lesion #2 was treated with pre-dilatation and placement of a 2.75mm x 20mm promus element¿ plus drug-eluting stent.Following post dilatation, residual stenosis was 0%.On the following day, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2018, patient presented to emergency department via emergency medical services (ems) with the complaints of recurrent chest pain associated with shortness of breath.The patient's cardiac enzymes were noted to be elevated and myocardial infarction was reported.Electrocardiogram revealed normal sinus rhythm, septal infract possible lateral infract.Subsequently, the patient was referred for cardiac catheterization and coronary angiography was performed.The 99% stenosis located in ostial portion of lcx was treated with balloon angioplasty and placement of 3.0 x 18mm non-bsc drug-eluting stent following post-dilation, the residual stenosis was 0% and timi 3 flow noted.On the next day, the event was considered as resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7290409
MDR Text Key100729365
Report Number2134265-2018-01277
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/06/2013
Device Model NumberH7493911416270
Device Catalogue Number39114-1627
Device Lot Number15744724
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/30/2018
Initial Date FDA Received02/22/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/03/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-